| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1992PNAS...89.3825M |
| P356 | DOI | 10.1073/PNAS.89.9.3825 |
| P953 | full work available at URL | https://europepmc.org/articles/PMC525583 |
| https://europepmc.org/articles/PMC525583?pdf=render | ||
| P932 | PMC publication ID | 525583 |
| P698 | PubMed publication ID | 1315042 |
| P5875 | ResearchGate publication ID | 21840750 |
| P50 | author | Ken Mackie | Q37831452 |
| P2093 | author name string | B. Hille | |
| P2860 | cites work | Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches | Q22337395 |
| Structure of a cannabinoid receptor and functional expression of the cloned cDNA | Q28240076 | ||
| Pharmacology and stereoselectivity of structurally novel cannabinoids in mice | Q28281676 | ||
| Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study | Q29615905 | ||
| Physiochemical properties, solubility, and protein binding of delta9-tetrahydrocannabinol | Q34220042 | ||
| Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. | Q34602111 | ||
| Membrane responses to norepinephrine in cultured brown fat cells | Q36410449 | ||
| Muscarinic activation of ionic currents measured by a new whole-cell recording method | Q36434152 | ||
| Brain voltage-sensitive calcium channel subtypes differentiated by omega-conotoxin fraction GVIA. | Q37408344 | ||
| The regulation and function of c-fos and other immediate early genes in the nervous system | Q37583743 | ||
| Calcium ions, active zones and synaptic transmitter release | Q38201298 | ||
| The physiological role of calcium-dependent channels | Q38208887 | ||
| Twelfth Gaddum memorial lecture. Drug receptors and the inhibition of nerve cells | Q38707891 | ||
| Health aspects of cannabis | Q39238279 | ||
| The central neuropharmacology of psychotropic cannabinoids | Q39632100 | ||
| Stereospecific presynaptic inhibitory effect of Δ9-tetrahydrocannabinol on cholinergic transmission in the myenteric plexus of the guinea pig | Q40209089 | ||
| Cannabinoid receptors and modulation of cyclic AMP accumulation in the rat brain | Q42479973 | ||
| Cannabinoid inhibition of adenylate cyclase. Biochemistry of the response in neuroblastoma cell membranes | Q44136954 | ||
| A diffusible second messenger mediates one of the pathways coupling receptors to calcium channels in rat sympathetic neurons | Q44854396 | ||
| Characterization of aminoalkylindole binding: selective displacement by cannabinoids | Q45122424 | ||
| High-affinity cannabinoid binding sites in brain membranes labeled with [3H]-5'-trimethylammonium delta 8-tetrahydrocannabinol | Q48459485 | ||
| Neuronal localization of cannabinoid receptors and second messengers in mutant mouse cerebellum | Q48705470 | ||
| Aminoalkylindoles: actions on specific G-protein-linked receptors | Q48752690 | ||
| Voltage- and calcium-activated potassium currents in mouse neuroblastoma x rat glioma hybrid cells. | Q52071084 | ||
| Noradrenaline- and Enkephalin-Induced Inhibition of Voltage-Sensitive Calcium Currents in NG108-15 Hybrid Cells. | Q55485459 | ||
| Gadolinium selectively blocks a component of calcium current in rodent neuroblastoma x glioma hybrid (NG108-15) cells. | Q55486365 | ||
| Nonclassical cannabinoid analgetics inhibit adenylate cyclase: development of a cannabinoid receptor model | Q68297258 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | calcium | Q706 |
| cannabinoids | Q422936 | ||
| P304 | page(s) | 3825-3829 | |
| P577 | publication date | 1992-05-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells | |
| P478 | volume | 89 |
| Q42556563 | (-)-Delta9-tetrahydrocannabinol antagonizes the peripheral cannabinoid receptor-mediated inhibition of adenylyl cyclase |
| Q37323369 | A cannabinoid receptor 1 mutation proximal to the DRY motif results in constitutive activity and reveals intramolecular interactions involved in receptor activation |
| Q44057993 | A critical role for a tyrosine residue in the cannabinoid receptors for ligand recognition |
| Q48150235 | A light and electron microscopic study of the CB1 cannabinoid receptor in primate brain |
| Q44345700 | A peripheral cannabinoid mechanism suppresses spinal fos protein expression and pain behavior in a rat model of inflammation |
| Q33839407 | A role for 2-arachidonoylglycerol and endocannabinoid signaling in the locomotor response to novelty induced by olfactory bulbectomy |
| Q27313563 | A role of CB1R in inducing θ-rhythm coordination between the gustatory and gastrointestinal insula |
| Q39271494 | A systems pharmacology perspective on the clinical development of Fatty Acid amide hydrolase inhibitors for pain |
| Q33922928 | A trace component of ginseng that inhibits Ca2+ channels through a pertussis toxin-sensitive G protein |
| Q92250735 | ABHD6: Its Place in Endocannabinoid Signaling and Beyond |
| Q28270589 | AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: implications for opioid/cannabinoid interaction studies |
| Q51246185 | Absence of cannabinoid 1 receptor in beta cells protects against high-fat/high-sugar diet-induced beta cell dysfunction and inflammation in murine islets. |
| Q43511723 | Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception |
| Q73457865 | Activation of CB1 cannabinoid receptors inhibits neurotransmitter release from identified synaptic sites in rat hippocampal cultures |
| Q42525505 | Activation of CB1 specifically located on GABAergic interneurons inhibits LTD in the lateral amygdala |
| Q41839263 | Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats |
| Q28270721 | Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1 |
| Q39897578 | Activation of the cannabinoid receptor type 1 decreases glutamatergic and GABAergic synaptic transmission in the lateral amygdala of the mouse |
| Q73575705 | Activational role of cannabinoids on movement |
| Q24681412 | Alzheimer's disease; taking the edge off with cannabinoids? |
| Q28235579 | An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing |
| Q88795293 | An overview of the cannabinoid type 2 receptor system and its therapeutic potential |
| Q30541205 | Analgesic effect of a mixed T-type channel inhibitor/CB2 receptor agonist |
| Q35657054 | Anandamide (arachidonylethanolamide), a brain cannabinoid receptor agonist, reduces sperm fertilizing capacity in sea urchins by inhibiting the acrosome reaction |
| Q48272826 | Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes. |
| Q38185073 | Anandamide in primary sensory neurons: too much of a good thing? |
| Q48251232 | Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase |
| Q36482564 | Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction |
| Q40483205 | Anandamide, an endogenous cannabinomimetic eicosanoid: ‘Killing two birds with one stone’ |
| Q47625816 | Antihyperalgesic effects of spinal cannabinoids |
| Q36731481 | Aspects of endocannabinoid signaling in periimplantation biology |
| Q47148004 | Assessing Allosteric Modulation of CB1 at the Receptor and Cellular Levels |
| Q35028253 | Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinol |
| Q40873810 | Behaviroal, pharmacological, and molecular characterization of an amphibian cannabinoid receptor |
| Q33900859 | Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol |
| Q90524726 | Brain activity of anandamide: a rewarding bliss? |
| Q26865295 | Brain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid system |
| Q28756500 | CB(1) cannabinoid receptor activation dose dependently modulates neuronal activity within caudal but not rostral song control regions of adult zebra finch telencephalon |
| Q35035833 | CB(1) cannabinoid receptor-G protein association: a possible mechanism for differential signaling |
| Q35232109 | CB(1) cannabinoid receptors and their associated proteins |
| Q47134613 | CB1 Receptor Signaling in the Brain: Extracting Specificity from Ubiquity |
| Q33833528 | CB1 allosteric modulator Org27569 is an antagonist/inverse agonist of ERK1/2 signaling |
| Q40862855 | CB1 cannabinoid receptor: cellular regulation and distribution in N18TG2 neuroblastoma cells. |
| Q37648995 | CB1 receptor-mediated signaling underlies the hippocampal synaptic, learning, and memory deficits following treatment with JWH-081, a new component of spice/K2 preparations |
| Q48280471 | CB1 receptors diminish both Ca(2+) influx and glutamate release through two different mechanisms active in distinct populations of cerebrocortical nerve terminals |
| Q24643895 | CB2 receptors in the brain: role in central immune function |
| Q73276348 | CP 55,940 protects against ischemia-induced electroencephalographic flattening and hyperlocomotion in Mongolian gerbils |
| Q48251433 | Calcium dependence of retrograde inhibition by endocannabinoids at synapses onto Purkinje cells. |
| Q39598750 | Cannabinoid 1 receptors are expressed by nerve growth factor- and glial cell-derived neurotrophic factor-responsive primary sensory neurones. |
| Q39549838 | Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons. |
| Q42082356 | Cannabinoid CB1 and CB2 Receptor Signaling and Bias |
| Q35047001 | Cannabinoid CB1 receptor-mediated modulation of evoked dopamine release and of adenylyl cyclase activity in the human neocortex |
| Q43260678 | Cannabinoid CB1 receptors fail to cause relaxation, but couple via Gi/Go to the inhibition of adenylyl cyclase in carotid artery smooth muscle |
| Q42150000 | Cannabinoid Modulation of Memory Consolidation in Rats: Beyond the Role of Cannabinoid Receptor Subtype 1 |
| Q43456804 | Cannabinoid Receptor Activation Differentially Modulates Ion Channels in Photoreceptors of the Tiger Salamander |
| Q55252194 | Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System. |
| Q34023746 | Cannabinoid WIN 55,212-2 regulates TRPV1 phosphorylation in sensory neurons |
| Q45072828 | Cannabinoid agonist, CP 55,940, prevents capsaicin-induced sensitization of spinal cord dorsal horn neurons |
| Q34490167 | Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain. |
| Q37752096 | Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas |
| Q44333682 | Cannabinoid and kappa opioid receptors reduce potassium K current via activation of G(s) proteins in cultured hippocampal neurons |
| Q37760048 | Cannabinoid conditioned reward and aversion: behavioral and neural processes. |
| Q48435185 | Cannabinoid effects in basal ganglia in a rat model of Parkinson's disease |
| Q77391993 | Cannabinoid receptor CB1 activates the Na+/H+ exchanger NHE-1 isoform via Gi-mediated mitogen activated protein kinase signaling transduction pathways |
| Q52027564 | Cannabinoid receptor activation in CA1 pyramidal cells in adult rat hippocampus. |
| Q47921662 | Cannabinoid receptor agonist efficacy for stimulating [35S]GTPgammaS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity. |
| Q43777397 | Cannabinoid receptor agonists inhibit depolarization-induced calcium influx in cerebellar granule neurons |
| Q48963650 | Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures |
| Q45015145 | Cannabinoid receptor agonists inhibit sensory nerve activation in guinea pig airways |
| Q35042740 | Cannabinoid receptor-mediated inhibition of acetylcholine release from hippocampal and cortical synaptosomes |
| Q48506995 | Cannabinoid receptor-mediated inhibition of the rat tail-flick reflex after microinjection into the rostral ventromedial medulla |
| Q41753811 | Cannabinoid receptors and their endogenous agonist, anandamide |
| Q36211444 | Cannabinoid receptors and their role in neuroprotection |
| Q28142578 | Cannabinoid receptors and their role in the regulation of the serotonin transporter in human placenta |
| Q35897353 | Cannabinoid signaling in glial cells |
| Q40700842 | Cannabinoid-induced motor incoordination through the cerebellar CB(1) receptor in mice |
| Q37812018 | Cannabinoid/Endocannabinoid Signaling Impact on Early Pregnancy Events |
| Q27336451 | Cannabinoids and Epilepsy. |
| Q38971616 | Cannabinoids and GI Disorders: Endogenous and Exogenous |
| Q55506613 | Cannabinoids and Reproduction: A Lasting and Intriguing History. |
| Q33819365 | Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research. |
| Q35100892 | Cannabinoids and cancer: pros and cons of an antitumour strategy |
| Q34786842 | Cannabinoids and cell fate. |
| Q34520143 | Cannabinoids and neuroprotection |
| Q48246173 | Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures |
| Q44209120 | Cannabinoids attenuate depolarization-dependent Ca2+ influx in intermediate-size primary afferent neurons of adult rats |
| Q28574512 | Cannabinoids attenuate norepinephrine-induced melatonin biosynthesis in the rat pineal gland by reducing arylalkylamine N-acetyltransferase activity without involvement of cannabinoid receptors |
| Q41695509 | Cannabinoids enhance NMDA-elicited Ca2+ signals in cerebellar granule neurons in culture. |
| Q38196398 | Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic. |
| Q89468008 | Cannabinoids in the descending pain modulatory circuit: Role in inflammation |
| Q52171870 | Cannabinoids reveal the necessity of hippocampal neural encoding for short-term memory in rats. |
| Q45153962 | Cannabinoids--signal transduction and mode of action |
| Q34549222 | Cannabis and cannabinoid receptors: from pathophysiology to therapeutic options |
| Q48405803 | Cannabis and endogenous cannabinoid systems. |
| Q34199483 | Cannabis and the brain |
| Q35035836 | Cell signaling by endocannabinoids and their congeners: questions of selectivity and other challenges |
| Q36990269 | Characterisation of cannabinoid 1 receptor expression in the perikarya, and peripheral and spinal processes of primary sensory neurons |
| Q49064700 | Characterization of the vasorelaxation to methanandamide in rat gastric arteries |
| Q48658239 | Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. |
| Q35784024 | Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence |
| Q28366505 | Control of Ca(2+) influx by cannabinoid and metabotropic glutamate receptors in rat cerebellar cortex requires K(+) channels |
| Q37718540 | Control of intracellular calcium signaling as a neuroprotective strategy |
| Q48339729 | Correlation between cannabinoid mediated effects on paired pulse depression and induction of long term potentiation in the rat hippocampal slice |
| Q36412421 | Custom distinctions in the interaction of G-protein beta subunits with N-type (CaV2.2) versus P/Q-type (CaV2.1) calcium channels |
| Q37575719 | Differential drug-drug interactions of the synthetic Cannabinoids JWH-018 and JWH-073: implications for drug abuse liability and pain therapy |
| Q44344553 | Differential effects of CB1 and opioid agonists on two populations of adult rat dorsal root ganglion neurons. |
| Q36858282 | Differential modulation of AP-1- and CRE-driven transcription by cannabinoid agonists emphasizes functional selectivity at the CB1 receptor |
| Q28366316 | Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide |
| Q47125735 | Do Cannabinoids Confer Neuroprotection Against Epilepsy? An Overview |
| Q41761143 | Does modulation of the endocannabinoid system have potential therapeutic utility in cerebellar ataxia? |
| Q44060463 | Dose-dependent effects of Delta9-tetrahydrocannabinol on rates of local cerebral glucose utilization in rat. |
| Q37310301 | Drug-Induced Alterations of Endocannabinoid-Mediated Plasticity in Brain Reward Regions |
| Q45111716 | Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease |
| Q37015427 | Drugs of abuse, immune modulation, and AIDS. |
| Q39635515 | Dual Neuroprotective and Neurotoxic Effects of Cannabinoid Drugs in Vitro |
| Q46667879 | Dual modulation of endocannabinoid transport and fatty acid amide hydrolase protects against excitotoxicity. |
| Q40673086 | Effect of arvanil (N-arachidonoyl-vanillyl-amine), a nonpungent anandamide-capsaicin hybrid, on ion currents in NG108-15 neuronal cells |
| Q48535697 | Effect of the cannabinoid receptor SPECT agent, AM 281, on hippocampal acetylcholine release from rat brain slices |
| Q42478605 | Effects of CB(1) cannabinoid receptor activation on cerebellar granule cell nitric oxide synthase activity |
| Q52541827 | Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding. |
| Q48433166 | Effects of a cannabinoid agonist on spinal nociceptive neurons in a rodent model of neuropathic pain |
| Q43158845 | Effects of cannabinoid receptor ligands on electrophysiological properties of myenteric neurones of the guinea-pig ileum |
| Q42528679 | Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain |
| Q42538308 | Effects of long-term exposure to delta9-THC on expression of cannabinoid receptor (CB1) mRNA in different rat brain regions |
| Q37692352 | Effects of opioids, cannabinoids, and vanilloids on body temperature |
| Q35047507 | Efficacy in CB1 receptor-mediated signal transduction |
| Q98464883 | Emerging Promise of Cannabinoids for the Management of Pain and Associated Neuropathological Alterations in Alzheimer's Disease |
| Q41602438 | Endocannabinoid CB1 receptor-mediated rises in Ca(2+) and depolarization-induced suppression of inhibition within the laterodorsal tegmental nucleus |
| Q38992137 | Endocannabinoid Signaling and the Hypothalamic-Pituitary-Adrenal Axis |
| Q92097847 | Endocannabinoid System and Alcohol Abuse Disorders |
| Q35532072 | Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors |
| Q36711160 | Endocannabinoid mechanisms of pain modulation |
| Q39267685 | Endocannabinoid modulation of dopamine neurotransmission |
| Q46750128 | Endocannabinoid signaling dynamics probed with optical tools. |
| Q37250243 | Endocannabinoid signaling in microglial cells |
| Q34967151 | Endocannabinoid signaling in midbrain dopamine neurons: more than physiology? |
| Q39368845 | Endocannabinoid system in neurodegenerative disorders. |
| Q30391852 | Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration |
| Q24564778 | Endocannabinoid-mediated long-term plasticity requires cAMP/PKA signaling and RIM1alpha |
| Q29042501 | Endocannabinoid-mediated synaptic plasticity and addiction-related behavior |
| Q42870301 | Endocannabinoids Potentiate Synaptic Transmission through Stimulation of Astrocytes |
| Q34641465 | Endocannabinoids and cannabinoid receptor genetics |
| Q37887826 | Endocannabinoids and stress |
| Q26765576 | Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease |
| Q34305700 | Endogenous cannabinoid as a retrograde messenger from depolarized postsynaptic neurons to presynaptic terminals |
| Q33940688 | Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses |
| Q44524201 | Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and neuroprotective actions of cannabinoids in neurons and glia. |
| Q35592076 | Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes |
| Q43064653 | Evaluation of the role of striatal cannabinoid CB1 receptors on movement activity of parkinsonian rats induced by reserpine |
| Q44164051 | Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity |
| Q48337260 | Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity |
| Q38072055 | Evidence for the involvement of cannabinoid receptors' polymorphisms in the pathophysiology of human diseases |
| Q44141821 | Evidence that anandamide-signaling regulates human sperm functions required for fertilization |
| Q48726145 | Examination of the effect of the cannabinoid receptor agonist, CP 55,940, on electrically evoked transmitter release from rat brain slices |
| Q37650292 | Examining the roles of cannabinoids in pain and other therapeutic indications: a review |
| Q44102387 | Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. |
| Q24309438 | Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations |
| Q52030475 | Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. |
| Q26777055 | Fetal Alcohol Spectrum Disorder: Potential Role of Endocannabinoids Signaling |
| Q34650334 | Frequency-specific and D2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling |
| Q34786818 | From cannabis to cannabinergics: new therapeutic opportunities |
| Q34233536 | Functional characterization and analgesic effects of mixed cannabinoid receptor/T-type channel ligands |
| Q44370323 | Functional significance of cannabinoid-mediated, depolarization-induced suppression of inhibition (DSI) in the hippocampus |
| Q34748762 | Hippocampal neurotoxicity of Delta9-tetrahydrocannabinol. |
| Q38340750 | Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia. |
| Q36452521 | Hypothalamic regulatory pathways and potential obesity treatment targets |
| Q34745063 | Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system |
| Q60583030 | Implicación del sistema cannabinoide endógeno en el alcoholismo |
| Q33751118 | In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liability |
| Q37133525 | Inflammation and aging: can endocannabinoids help? |
| Q39084202 | Inflammation of peripheral tissues and injury to peripheral nerves induce differing effects in the expression of the calcium-sensitive N-arachydonoylethanolamine-synthesizing enzyme and related molecules in rat primary sensory neurons. |
| Q35042648 | Influence of cannabinoids on the delayed rectifier in freshly dissociated smooth muscle cells of the rat aorta |
| Q48452719 | Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum. |
| Q39124297 | Inhibition of interleukin-8 release in the human colonic epithelial cell line HT-29 by cannabinoids |
| Q38203030 | Interplay between synaptic endocannabinoid signaling and metaplasticity in neuronal circuit function and dysfunction |
| Q35310056 | Intracellular cannabinoid type 1 (CB1) receptors are activated by anandamide |
| Q42471169 | Involvement of the carboxyl terminus of the third intracellular loop of the cannabinoid CB1 receptor in constitutive activation of Gs. |
| Q47963301 | Ipsilateral turning behavior induced by unilateral microinjections of a cannabinoid into the rat subthalamic nucleus |
| Q84959734 | L-type calcium channel mediates anticonvulsant effect of cannabinoids in acute and chronic murine models of seizure |
| Q34412157 | Ligand Binding Sensitivity of the Extracellular Loop Two of the Cannabinoid Receptor 1. |
| Q33821608 | Local administration of delta9-tetrahydrocannabinol attenuates capsaicin-induced thermal nociception in rhesus monkeys: a peripheral cannabinoid action |
| Q31813503 | Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. |
| Q51985298 | Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study. |
| Q48144821 | Long-term behavioral and biochemical effects of an ultra-low dose of Δ9-tetrahydrocannabinol (THC): neuroprotection and ERK signaling |
| Q47729000 | Long-term depression of inhibitory synaptic transmission induced by spike-timing dependent plasticity requires coactivation of endocannabinoid and muscarinic receptors |
| Q33823548 | Long-term synaptic transformation of hippocampal CA1 gamma-aminobutyric acid synapses and the effect of anandamide |
| Q40878576 | Marijuana. Respiratory tract effects |
| Q34347280 | Marijuana: respiratory tract effects |
| Q33199898 | Mechanisms underlying cannabinoid inhibition of presynaptic Ca2+ influx at parallel fibre synapses of the rat cerebellum |
| Q35683329 | Meta-Analysis of Public Microarray Datasets Reveals Voltage-Gated Calcium Gene Signatures in Clinical Cancer Patients |
| Q38209755 | Mitochondria: a possible nexus for the regulation of energy homeostasis by the endocannabinoid system? |
| Q37683535 | Modulating excitation through plasticity at inhibitory synapses. |
| Q42942224 | Modulation of N-type calcium currents by presynaptic imidazoline receptor activation in rat superior cervical ganglion neurons |
| Q41378151 | Modulation of network oscillatory activity and GABAergic synaptic transmission by CB1 cannabinoid receptors in the rat medial entorhinal cortex. |
| Q41371378 | Modulation of neurotransmission by cannabinoids in the basal ganglia |
| Q34247711 | Modulation of pain transmission by G-protein-coupled receptors |
| Q39650639 | Modulation of sensory neuron potassium conductances by anandamide indicates roles for metabolites |
| Q89373183 | Modulation of the Cannabinoid System: A New Perspective for the Treatment of the Alzheimer's Disease |
| Q39124226 | Modulation of the release of endogenous adenosine by cannabinoids in the myenteric plexus-longitudinal muscle preparation of the guinea-pig ileum |
| Q34167072 | Modulation of the serotonin system by endocannabinoid signaling |
| Q41191025 | Molecular neurobiology of the cannabinoid receptor. |
| Q45154605 | NMR structural comparison of the cytoplasmic juxtamembrane domains of G-protein-coupled CB1 and CB2 receptors in membrane mimetic dodecylphosphocholine micelles |
| Q36717019 | Natural prenylated resveratrol analogs arachidin-1 and -3 demonstrate improved glucuronidation profiles and have affinity for cannabinoid receptors |
| Q30493991 | Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity. |
| Q47725960 | Neurophysiological evidence for the presence of cannabinoid CB1 receptors in the laterodorsal tegmental nucleus. |
| Q35682291 | Neurotransmitter modulation of neuronal calcium channels. |
| Q30540681 | Obesity-driven synaptic remodeling affects endocannabinoid control of orexinergic neurons |
| Q37568602 | Organized trafficking of anandamide and related lipids |
| Q33893580 | Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse. |
| Q38756895 | Pharmacological characterization of inhibitory effects of postsynaptic opioid and cannabinoid receptors on calcium currents in neonatal rat nucleus tractus solitarius |
| Q92097863 | Pharmacology of Medical Cannabis |
| Q34442847 | Pharmacology of cannabinoid CB1 and CB2 receptors. |
| Q35884483 | Physiological and behavioural effects of the endogenous cannabinoid, arachidonylethanolamide (anandamide), in the rat. |
| Q78727774 | Plant-derived, synthetic and endogenous cannabinoids as neuroprotective agents. Non-psychoactive cannabinoids, 'entourage' compounds and inhibitors of N-acyl ethanolamine breakdown as therapeutic strategies to avoid pyschotropic effects |
| Q37352175 | Post-ischemic brain damage: the endocannabinoid system in the mechanisms of neuronal death |
| Q48735695 | Presynaptic calcium channel inhibition underlies CB₁ cannabinoid receptor-mediated suppression of GABA release. |
| Q43999138 | Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses. |
| Q37641791 | Presynaptic cell dependent modulation of inhibition in cortical regions |
| Q44169957 | Presynaptic factors in the regulation of DSI expression in hippocampus |
| Q28363375 | Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons |
| Q39750122 | Presynaptic specificity of endocannabinoid signaling in the hippocampus |
| Q28144567 | Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons |
| Q37372676 | Production and physiological actions of anandamide in the vasculature of the rat kidney. |
| Q36625465 | Profiling two indole-2-carboxamides for allosteric modulation of the CB1 receptor. |
| Q34956779 | Protection of neurons in the retinal ganglion cell layer against excitotoxicity by the N-acylethanolamine, N-linoleoylethanolamine |
| Q52529851 | Protein kinase C disrupts cannabinoid actions by phosphorylation of the CB1 cannabinoid receptor. |
| Q38774127 | Pyrimidinyl Biphenylureas: Identification of New Lead Compounds as Allosteric Modulators of the Cannabinoid Receptor CB1. |
| Q36514515 | Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signaling. |
| Q27310866 | Receptor heteromerization expands the repertoire of cannabinoid signaling in rodent neurons |
| Q43597369 | Receptor-independent effects of natural cannabinoids in rat peritoneal mast cells in vitro |
| Q48298650 | Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice |
| Q36999038 | Regulation of CB1 cannabinoid receptor internalization by a promiscuous phosphorylation-dependent mechanism. |
| Q37406777 | Regulation of divalent metal transporter-1 by serine phosphorylation |
| Q48559047 | Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain |
| Q34315849 | Retrograde endocannabinoid signaling in a postsynaptic neuron/synaptic bouton preparation from basolateral amygdala |
| Q34166712 | Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids |
| Q28574390 | Retroinhibition of presynaptic Ca2+ currents by endocannabinoids released via postsynaptic mGluR activation at a calyx synapse |
| Q36967863 | Role of cannabinoids and endocannabinoids in cerebral ischemia |
| Q44865127 | Role of the endogenous cannabinoid system as a modulator of dopamine transmission: implications for Parkinson's disease and schizophrenia |
| Q38315259 | Role of the highly conserved Asp-Arg-Tyr motif in signal transduction of the CB2 cannabinoid receptor |
| Q60155183 | Role of the superior colliculus in the motor effects of cannabinoids and dopamine |
| Q36373102 | Roles for the endocannabinoid system in ethanol-motivated behavior. |
| Q47628019 | SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice |
| Q53692390 | Sensitization of C-fiber nociceptors in mice with sickle cell disease is decreased by local inhibition of anandamide hydrolysis. |
| Q35035850 | Spinal and peripheral mechanisms of cannabinoid antinociception: behavioral, neurophysiological and neuroanatomical perspectives |
| Q43792410 | Structural domains of the CB1 cannabinoid receptor that contribute to constitutive activity and G-protein sequestration. |
| Q41214405 | Structural features of the central cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR 141716A. |
| Q37040227 | Synaptic targets of Δ9-tetrahydrocannabinol in the central nervous system. |
| Q39244593 | Synergistic interaction of pregabalin with the synthetic cannabinoid WIN 55,212-2 mesylate in the hot-plate test in mice: an isobolographic analysis. |
| Q43581403 | Tetrahydrocannabinol-induced apoptosis of cultured cortical neurones is associated with cytochrome c release and caspase-3 activation |
| Q36176455 | The CB1 cannabinoid receptor C-terminus regulates receptor desensitization in autaptic hippocampal neurones |
| Q39274311 | The Central Role of Glia in Pathological Pain and the Potential of Targeting the Cannabinoid 2 Receptor for Pain Relief |
| Q38659944 | The Endocannabinoid Signaling System in the CNS: A Primer. |
| Q50226059 | The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction. |
| Q42805458 | The FGF receptor uses the endocannabinoid signaling system to couple to an axonal growth response |
| Q37793366 | The Multiplicity of Action of Cannabinoids: Implications for Treating Neurodegeneration |
| Q43906984 | The cannabinoid CB1 receptor mediates retrograde signals for depolarization-induced suppression of inhibition in cerebellar Purkinje cells. |
| Q48318429 | The cannabinoid WIN 55,212-2-mediated protection of dentate gyrus granule cells is driven by CB1 receptors and modulated by TRPA1 and Cav 2.2 channels. |
| Q43991156 | The cannabinoid agonist DALN positively modulates L-type voltage-dependent calcium-channels in N18TG2 neuroblastoma cells |
| Q34245210 | The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins. |
| Q48482096 | The cannabinoid agonist Win55,212-2 inhibits calcium channels by receptor-mediated and direct pathways in cultured rat hippocampal neurons |
| Q38115637 | The cannabinoid receptor 1 and its role in influencing peripheral metabolism. |
| Q34659000 | The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia. |
| Q52279693 | The cannabinoid receptor gene (CNR1) is not affected in German i.v. drug users. |
| Q36944706 | The complications of promiscuity: endocannabinoid action and metabolism |
| Q30719728 | The cytoplasmic helix of cannabinoid receptor CB2, a conformational study by circular dichroism and (1)H NMR spectroscopy in aqueous and membrane-like environments |
| Q35193273 | The dual neuroprotective-neurotoxic profile of cannabinoid drugs |
| Q28137626 | The effects of cannabinoids on the brain |
| Q44275827 | The effects of delta9-tetrahydrocannabinol physical dependence on brain cannabinoid receptors |
| Q42110966 | The endocannabinoid 2-arachidonoylglycerol is responsible for the slow self-inhibition in neocortical interneurons |
| Q34305854 | The endocannabinoid nervous system: unique opportunities for therapeutic intervention |
| Q37393042 | The endocannabinoid system and sex steroid hormone-dependent cancers. |
| Q34587990 | The endocannabinoid system as a target for the treatment of visceral obesity and metabolic syndrome |
| Q24648473 | The endocannabinoid system as an emerging target of pharmacotherapy |
| Q34099000 | The endocannabinoid system: a physiological perspective on its role in psychomotor control |
| Q35954057 | The endocannabinoid system: physiology and pharmacology. |
| Q34786832 | The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspects. |
| Q29615356 | The molecular logic of endocannabinoid signalling |
| Q24522320 | The neurobiology and evolution of cannabinoid signalling |
| Q77354791 | The proximal and distal C-terminal tail domains of the CB1 cannabinoid receptor mediate G protein coupling |
| Q34268475 | The role of cannabinoids in neurodegenerative diseases |
| Q34320270 | The role of endocannabinoids in pain modulation |
| Q45266148 | The role of potassium BK channels in anticonvulsant effect of cannabidiol in pentylenetetrazole and maximal electroshock models of seizure in mice |
| Q37402927 | The therapeutic potential of novel cannabinoid receptors |
| Q34974856 | The therapeutic potential of the cannabinoids in neuroprotection |
| Q33964721 | Therapeutic potential of cannabinoids in CNS disease |
| Q74501955 | [The pharmacology of cannabinoid derivatives: are there applications to treatment of pain?] |
Search more.